Induction paclitaxel/carboplatin followed by radiotherapy and paclitaxel shows promising efficacy in unresectable non-small-cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status

By Chang Gee-Chen   Chen Kun-Chieh   Yang Tsung-Ying   Yin Ming-Chang   Lin Ching-Pei   Kuo Benjamin Ing-Tiau   Hsu Jeng-Yuan  

Investigational New Drugs, Vol. 23, Iss. 1, 2005-01 ,pp. : 73-77

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

By Ho Cheryl   Davies Angela   Sangha Randeep   Lau Derick   Lara Primo   Chew Helen   Beckett Laurel   Mack Philip   Riess Jonathan   Gandara David  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1587-1591

Springer Publishing Company

Access to resources Recommend Favorite

Axitinib for the treatment of advanced non-small-cell lung cancer

By King Judy W  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 765-773

Informa Healthcare

Access to resources Recommend Favorite

Advances in chemotherapy in advanced non-small-cell lung cancer

By Maione Paolo   Rossi Antonio   Sacco Paola Claudia   Bareschino Maria Anna   Schettino Clorinda   Gridelli Cesare  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2997-3007

Informa Healthcare

Access to resources Recommend Favorite